Dr Joe Zhu
Honorary Conjoint Senior Fellow
The Sir Peter MacCallum Department of Oncology
34 Scholarly works
1 Projects
HIGHLIGHTS
2026
Journal article
ENHANCING CHIMERIC ANTIGEN RECEPTOR (CAR) T CELL THERAPY FOR PAEDIATRIC SARCOMA THROUGH CAR T ENGINEERING AND TUMOUR MICROENVIRONMENT REWIRING
DOI: 10.1016/j.jcyt.2026.1022252025
Conference Proceedings
Development of a novel CAR-T cell therapy using a multimodal approach to target T cell lymphoma
DOI: 10.1182/blood-2025-41122025
Journal article
Personalized Immunotherapy for T Cell Lymphomas: From Immune Escape to Precision Therapeutics
DOI: 10.3390/jpm151105602025
Journal article
A novel switch receptor enhances CAR-T cell fitness in TGF-β-enriched solid tumors 3396
DOI: 10.1093/jimmun/vkaf283.12072024
Conference Proceedings
309 Engineering a novel switch receptor enhances CAR-T cell fitness in suppressive TGF-β-enriched solid tumors
DOI: 10.1136/jitc-2024-sitc2024.03092024
Journal article
Efficient generation of human NOTCH ligand-expressing haemogenic endothelial cells as infrastructure for in vitro haematopoiesis and lymphopoiesis
DOI: 10.1038/s41467-024-51974-72022
Research grants (ARC, NHMRC, MRFF)
Targeting Cold Tumours With Triple Therapy
RECENT SCHOLARLY WORKS
2024
Journal article
FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy
DOI: 10.1038/s41586-024-07242-12023
Journal article
Low-dose carboplatin modifies the tumor microenvironment to augment CAR T cell efficacy in human prostate cancer models
DOI: 10.1038/s41467-023-40852-32023
Conference Proceedings
Modifying the tumour microenvironment using carboplatin to enhance the efficacy of CAR T cell therapy for prostate cancer
2023
Journal article
TSTEM-like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical models
DOI: 10.1126/scitranslmed.abk1900